A research by Fermaglich and Miller (2023) evaluated tendencies in orphan drug designation and approval following the passage of the Orphan Drug Act of 1983 within the US. The authors use FDA information to judge between 1983 and 2022 and conclude that: In the course of the forty years of the ODA's existence, 6,340 orphan […]